EUVIMEDEUVIMED entdecken
Crossref

Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy

Yanli Miao, Yi Zhong, Yutian Li, Haojie Qin, Ling Yang, Guojun Cao, Yong Tang, Ting Yu, Di Fan, Yang Lu, Jiangtong Peng iD, Kai Huang iD

Diabetes · 2024

DOI: 10.2337/db23-0688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yanli Miao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Autophagy, HSP20 Heat-Shock Proteins, Mitogen-Activated Protein Kinase 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heat shock protein 20 (HSP20) emerges as a novel regulator of autophagy in the heart. Nonetheless, the detailed function of HSP20 in liver and its effect on autophagy remain unknown. Here, we observed that HSP20 expression is increased in liver tissues from mice and patients with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD). Liver-specific downregulation of HSP20 mitigates hepatic steatosis and insulin resistance in obese mice, while upregulating HSP20 promotes lipid deposition and hepatocyte cell death. Mechanistically, Liquid chromatography tandem mass spectrometry (LC-MS/MS) revealed that HSP20 interacts with phosphorylated extracellular regulated protein kinases 2 (ERK2) and prevents its dephosphorylation by dual specificity phosphatase 6 (DUSP6), leading to ERK2-mediated repression of autophagy, resulting in aggravated saturated fatty acid (SFA)-triggered hepatocyte death. Importantly, such adverse effects could be ameliorated by ERK inhibitor. Our data reveals a framework of how HSP20 increases susceptibility of SFA-induced liver injury through enhancing ERK2 phosphorylation, which represents a plausible therapeutic intervention to combat MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyHSP20 Heat-Shock ProteinsMitogen-Activated Protein Kinase 1AnimalsHumansMaleMiceHepatocytesInsulin ResistanceLiverMice, Inbred C57BLNon-alcoholic Fatty Liver DiseasePhosphorylation

Substanzen

HSP20 Heat-Shock ProteinsHSPB6 protein, humanMAPK1 protein, humanMapk1 protein, mouseMitogen-Activated Protein Kinase 1Hspb6 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH.
  • Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

ORCID-Profile: Jiangtong Peng, Kai Huang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Miao, Y., Zhong, Y., Li, Y., Qin, H., Yang, L., Cao, G., Tang, Y., Yu, T., Fan, D., Lu, Y., Peng, J., & Huang, K. (2024). Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy. Diabetes. https://doi.org/10.2337/db23-0688

Vancouver

Miao Y, Zhong Y, Li Y, Qin H, Yang L, Cao G, et al. Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy. Diabetes. 2024. doi:10.2337/db23-0688

BibTeX
@article{Miao2024,
  author = {Miao, Yanli and Zhong, Yi and Li, Yutian and Qin, Haojie and Yang, Ling and Cao, Guojun and Tang, Yong and Yu, Ting and Fan, Di and Lu, Yang and Peng, Jiangtong and Huang, Kai},
  title = {Inhibition of HSP20 ameliorates steatotic liver disease by stimulating ERK2-dependent autophagy},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db23-0688}
}
Kostenlos starten →